Exploring the possible binding sites at the interface of triosephosphate isomerase dimer as a potential target for anti-tripanosomal drug design

L. Michel Espinoza-Fonseca, José G. Trujillo-Ferrara

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

To explore the possible binding sites at the interface of tripanosomal triosephosphate isomerase, fully flexible benzothiazoles were docked onto the dimer interface. Docking studies revealed that the most favorable interactions occur in the aromatic clusters of the dimeric form. Hence is purposed that the dimer disruption is not via Cys 15, as presented in last studies, but it could be carried out through the unstabilization of π-π interactions of two aromatic clusters present in the interface. These studies enable a novel alternative for rational structure-based anti-tripanosomal drug design.

Original languageEnglish (US)
Pages (from-to)3151-3154
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume14
Issue number12
DOIs
StatePublished - Jun 21 2004

Bibliographical note

Funding Information:
We thank Drs. Armando Gómez-Puyou, Ruy Pérez-Montfort and Arturo Rojo-Dominguez for fruitful discussions about this work. This work was supported under CONACYT and CGPI-IPN grants 31935 and 200860.

Fingerprint Dive into the research topics of 'Exploring the possible binding sites at the interface of triosephosphate isomerase dimer as a potential target for anti-tripanosomal drug design'. Together they form a unique fingerprint.

Cite this